Oğuzhan Işılay on Stabilizing Human Blood Clotting Factor VIII
Oğuzhan Işılay, Bioinformatics Intern at Mersin Üniversity, shared on LinkedIn:
”I recently read and analyzed an interesting research paper on stabilizing Human Blood Clotting Factor VIII (FVIII) using proteins derived from tardigrades.
FVIII is a critical therapeutic protein used in the treatment of Hemophilia A, but it is highly unstable and requires strict cold-chain storage.
This creates major logistical and economic challenges, especially in low-resource settings.
The study explored whether proteins associated with desiccation tolerance in tardigrades (such as CAHS and SAHS proteins) could protect FVIII during repeated drying and rehydration cycles.
Remarkably, some tardigrade proteins preserved FVIII activity significantly better than commonly used stabilizers like trehalose, even after multiple stress cycles.
What I found particularly interesting is the broader implication: bio-inspired stabilization strategies could reduce cold-chain dependency and improve global access to protein-based therapeutics.
This analysis reinforced how concepts from extremophile biology can be directly translated into real-world biotechnological and medical solutions.
Reference.”
Read the full article here.
Article: Natural and engineered mediators of desiccation tolerance stabilize Human Blood Clotting Factor VIII in a dry state
Authors: Maxwell H. Packebush, Silvia Sanchez-Martinez, Sourav Biswas, Shraddha KC, Kenny H. Nguyen, John F. Ramirez, Vincent Nicholson, Thomas C. Boothby

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026